MLN 3897

CAS No. 1010731-97-1

MLN 3897( AVE 9897 )

Catalog No. M10069 CAS No. 1010731-97-1

MLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 404 Get Quote
10MG 608 Get Quote
25MG 1039 Get Quote
50MG 1555 Get Quote
100MG 2336 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MLN 3897
  • Note
    Research use only, not for human use.
  • Brief Description
    MLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays.
  • Description
    MLN 3897 is a potent, specific and orally active antagonist of CCR1 with IC50 of 0.8 nM in competition binding assays, 500-fold selectivity over CCR5; inhibits osteoclastogenesis and OC activity by impairing multinucleation and by down-regulation of c-fos signaling, inhibits osteoclastogenesis and OC activity by impairing multinucleation and by down-regulation of c-Fos signaling; demonstrates potential for the treatment of multiple sclerosis and rheumatoid arthritis.Multiple Sclerosis Phase 1 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AVE 9897
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    Multiple Sclerosis

Chemical Information

  • CAS Number
    1010731-97-1
  • Formula Weight
    535.125
  • Molecular Formula
    C32H39ClN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@@]1(C2=CC=C(Cl)C=C2)C(C)(C)CN(CC/C=C3C(C=CCN4)=C4COC5=CC=C(C(C)(O)C)C=C\35)CC1
  • Chemical Name
    (S,E)-4-(4-chlorophenyl)-1-(3-(7-(2-hydroxypropan-2-yl)-2,11-dihydrobenzo[6,7]oxepino[3,4-b]pyridin-5(1H)-ylidene)propyl)-3,3-dimethylpiperidin-4-ol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Gilchrist A, et al. Br J Pharmacol. 2014 Nov;171(22):5127-38. 2. Vallet S, et al. Blood. 2007 Nov 15;110(10):3744-52. 3. Lu C, et al. J Pharmacol Exp Ther. 2010 Feb;332(2):562-8. 4. Vergunst CE, et al. Arthritis Rheum. 2009 Dec;60(12):3572-81.
molnova catalog
related products
  • IT1t

    A highly potent, selective, orally bioavailable CXCR4 inhibitor with binding IC50 of 8 nM for hCXCR4, IC50 of 1.1 nM in Ca2+-mobilization assays.

  • CCR10 antagonist 1

    CCR10 antagonist 1 is a potent, selective CCR10 antagonist with IC50 of 690 nM.

  • CCX140

    A potent, selective, orally bioavailable CCR2 antagonist with Kd of 2.3 nM for hCCR2.